In these studies, SEMA3B-AS1 was confirmed to inhibit the progression of cardiac adenocarcinoma and to be closely related to the progression and prognosis of esophageal squamous cell carcinoma. The gene discussed is SEMA3B; the disease is esophageal squamous cell carcinoma.